Dr. Berlanda Scorza is Vice President for Global Health R&D Vaccines and GVGH Institute Director. GVGH is a key component of GSK’s commitment to Global Health, dedicated to developing effective and affordable vaccines for neglected infectious diseases that affect communities in low- and middle-income countries.

Prior to joining GSK in 2020, Dr. Berlanda Scorza was a Senior Program Officer at the Bill and Melinda Gates Foundation and Senior Director for vaccine development at PATH, where he led programs to develop seasonal and pandemic influenza vaccines.

Previously, he was a senior scientist at Chiron and Novartis Vaccines, where he contributed to developing a replicon RNA vaccine, a cell-cultured influenza vaccine (Flucelvax), and a bacterial vaccine platform (GMMA). Dr. Berlanda Scorza received his Ph.D. from the University of Milano Bicocca and completed his post-doctoral studies at Imperial College London.